GlassScriptPhysician profile
Samir A Shah
NPI 1871545434
$7,149.73
in general payments reported to CMS, 2019-2025
20 companies · $1,883 in 2025
The $1,883 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,639 · 2020: $257 · 2021: $285 · 2022: $675 · 2023: $2,150 · 2024: $262 · 2025: $1,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,050 · Food and Beverage: $1,195 · Entertainment: $49.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,050.00 |
| Food and Beverage | $1,194.87 |
| Entertainment | $49.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $3,222.17 | 2021-2025 | Iaccess Precision Blade, Idosetr |
| Alcon Vision LLC | $2,137.39 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| Rxsight INC | $485.85 | 2022-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Surgical Vision, INC. | $320.31 | 2019-2023 | Tecnis Iol, Catalys System |
| Sight Sciences, INC. | $182.55 | 2019-2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $132.90 | 2022-2025 | Scoutpro Osmolarity System |
| Horizon Therapeutics Plc | $87.40 | 2019-2022 | |
| Optos, INC. | $84.15 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $83.94 | 2019-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.54 | 2019-2021 | |
| Lensar, INC. | $64.48 | 2019 | |
| New World Medical,INC. | $47.20 | 2019-2025 | Clearpath, Kahook Dual Blade, Via360 |
| Nova Eye, INC. | $39.00 | 2024 | |
| Amgen INC. | $38.27 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $37.53 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $36.89 | 2019 | |
| Abbvie INC. | $34.11 | 2024 | |
| Thea Pharma INC. | $19.21 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.